Xu X P, Liu Y, Tanner M A, Sturek M, Myers P R
Department of Physiology, University of Missouri, Columbia, Missouri 65211, USA.
J Cell Physiol. 1996 Sep;168(3):539-48. doi: 10.1002/(SICI)1097-4652(199609)168:3<539::AID-JCP6>3.0.CO;2-Q.
The purpose of this study was to test the hypothesis that endothelial cells from resistance arteries and epicardial conduit coronary arteries differ in their expression of nitric oxide synthase (NOS) and calcium metabolism, and that these differences contribute to the mechanism underlying disparate physiological vasodilator responses observed between the two populations of vessels. The functional vasodilator responses of isolated resistance arteries and epicardial conduit coronary arteries were compared in vitro using both the receptor-independent agonist A23187 ionophore to increase intracellular calcium and the receptor-dependent agonist bradykinin. Constitutive NOS (cNOS) activity in monocultures of endothelial cells derived from resistance arteries and conduit arteries was assayed using a fibroblast-reporter cell method. Intracellular calcium concentration was assessed using fura-2 microfluorometry. Nitric oxide production was determined using a chemiluminescence technique, while cNOS protein was quantitated by Western blot analysis. A23187 was a less potent vasodilator of resistance arteries studied in vitro, compared to epicardial conduit arteries (EC50 = 1.6 microM, resistance artery vs. EC50 = 0.03 microM, conduit artery); however, bradykinin was more potent in resistance arteries (EC50 = 0.3 nM, resistance artery vs. EC50 = 2 nM, conduit artery). In pure monocultures of endothelium, nitric oxide production measured by chemiluminescence both basally and in response to A23187 was significantly less in resistance arteries (6.1 +/- 0.5, basal vs. 10.80 +/- 0.55, stimulated nmol/microgram protein), compared to conduit arteries (7.7 +/- 0.5, basal vs. 17.00 +/- 1.52, stimulated nmol/microgram protein; P < 0.05 resistance artery endothelium vs. conduit artery endothelium). cNOS enzyme activity assessed by cGMP production in reporter cell fibroblasts was also lower in resistance arteries compared to conduit arteries (0.17 +/- 0.03 vs. 0.33 +/- 0.05 fmol cGMP/microgram protein, respectively; P < 0.05 resistance artery endothelium vs. conduit artery endothelium). Conduit arteries expressed 2.1 x more cNOS protein than resistance arteries, as assessed by Western blotting of cellular homogenates. No significant differences were found with microfluorimetry in either basal or ionophore-stimulated intracellular calcium concentrations. The results signified that porcine resistance arteries expressed less NOS and produced less nitric oxide than epicardial conduit arteries both basally and in response to an increase in intracellular calcium. This difference was reflected functionally as a decreased vasodilatory response to increased intracellular calcium in resistance arteries that could not be explained on the basis of differences in the metabolism of intracellular calcium. In contrast, the functional vasodilator response of intact vessels to a receptor-mediated agonist was enhanced in resistance arteries compared to conduit arteries, suggesting an important role of signal transduction mechanisms in specific physiological responses. Thus, the ability of the endothelium to regulate on a regional basis the expression of NOS and integrate receptor-mediated responses with these differences may provide a mechanism for diverse vasomotor responses in different populations of vessels.
阻力动脉和心外膜冠状动脉的内皮细胞在一氧化氮合酶(NOS)表达和钙代谢方面存在差异,且这些差异有助于解释在这两种血管中观察到的不同生理血管舒张反应的机制。在体外,使用不依赖受体的激动剂A23187离子载体增加细胞内钙,以及依赖受体的激动剂缓激肽,比较分离的阻力动脉和心外膜冠状动脉的功能性血管舒张反应。使用成纤维细胞报告细胞法测定来自阻力动脉和冠状动脉的内皮细胞单培养物中的组成型NOS(cNOS)活性。使用fura-2显微荧光测定法评估细胞内钙浓度。使用化学发光技术测定一氧化氮生成量,同时通过蛋白质印迹分析对cNOS蛋白进行定量。与心外膜冠状动脉相比,在体外研究中,A23187对阻力动脉的血管舒张作用较弱(阻力动脉的EC50 = 1.6 microM,冠状动脉的EC50 = 0.03 microM);然而,缓激肽对阻力动脉的作用更强(阻力动脉的EC50 = 0.3 nM,冠状动脉的EC50 = 2 nM)。在纯内皮细胞单培养物中,通过化学发光法测定的基础状态下以及对A23187反应时的一氧化氮生成量,阻力动脉显著低于冠状动脉(基础状态下:阻力动脉为6.1±0.5,冠状动脉为7.7±0.5;刺激后:阻力动脉为10.80±0.55,冠状动脉为17.00±1.52 nmol/μg蛋白;阻力动脉内皮与冠状动脉内皮相比,P < 0.05)。通过报告细胞成纤维细胞中cGMP生成评估的cNOS酶活性,阻力动脉也低于冠状动脉(分别为0.17±0.03与0.33±0.05 fmol cGMP/μg蛋白;阻力动脉内皮与冠状动脉内皮相比,P < 0.05)。通过细胞匀浆的蛋白质印迹分析评估,冠状动脉表达的cNOS蛋白比阻力动脉多2.1倍。在基础状态或离子载体刺激后的细胞内钙浓度方面,显微荧光测定法未发现显著差异。结果表明,猪的阻力动脉基础状态下以及对细胞内钙增加的反应中,表达的NOS较少,产生的一氧化氮也较少。这种差异在功能上表现为阻力动脉对细胞内钙增加的血管舒张反应减弱,而这不能基于细胞内钙代谢的差异来解释。相反,与冠状动脉相比,完整血管对受体介导的激动剂的功能性血管舒张反应在阻力动脉中增强,表明信号转导机制在特定生理反应中起重要作用。因此,内皮细胞在区域基础上调节NOS表达并将受体介导的反应与这些差异整合的能力,可能为不同血管群体中的多种血管运动反应提供一种机制。